摘要：This paper evaluates the data describing respiratory syncytial virus (RSV) infection in infants and children aged less than five years in NSW, and in particular children aged less than one year. This younger age group forms the primary target group for immunisation against RSV and vaccine development is now well advanced. The data outlined in this paper provide a baseline for evaluating the burden of disease before and after the introduction of a vaccine.
